clinical trial · NCT05168826
China S3 PMS: SAPIEN 3 China Post Market Registry Study
Edwards Lifesciences·—·active not recruiting·n = 250
Aortic Stenosis, SevereSAPIEN 3 Transcatheter Heart Valve
brief summary
The objective of this study is to evaluate the long term safety and effectiveness of the SAPIEN 3 Transcatheter Heart Valve system in real world setting.
started
Jan 24, 2022
primary completion
Dec 1, 2035
completion
Dec 1, 2035
last updated
Jul 30, 2025
detailed description
This is an observational, single-arm, multicentre, post-market study.
official title
SAPIEN 3 China Post Market Registry Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol